Insider · CIK 0001724161
Jeff L Vacirca
Files at CAI (Caris Life Sciences, Inc.). First filing May 12, 2026, latest May 12, 2026.
In brief
Jeff L Vacirca files SEC Form 4 as director at CAI (Caris Life Sciences, Inc.). Since May 12, 2026, Jeff L Vacirca has reported 1 open-market buy worth $501k and 0 open-market sells worth $0, the latest filed on May 12, 2026.
A track record needs three past buys with six months of prices behind them; Jeff L Vacirca has 0, so none is measured yet.
The newest scored trade: bought $501k of CAI on May 11, 2026, filed May 12, 2026, scored 69 (notable). In the last 12 months: 1 buy worth $501k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAI: Caris Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 69Notable | Caris Life Sciences, Inc. | $501k 31,050 shares | +167% | 0% from low-59% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +13,192 | $0.00 | $0 | 62,863 | Aug 14, 2026 |
| May 11, 2026 | CAI Caris Life Sciences, Inc. | POpen-market purchase Common Stock | +31,050 | $16.15 | $501k | 49,671 | May 12, 2026 |
| Feb 26, 2026 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +2,492 | $20.06 | $50k | 18,621 | Feb 27, 2026 |
Questions about Jeff L Vacirca
Answered from the filings on this page, as of the latest one.
Is Jeff L Vacirca buying or selling?
In the last 12 months Jeff L Vacirca reported 1 open-market buy worth $501k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $501k of CAI on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Jeff L Vacirca's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff L Vacirca has 0.
Where does Jeff L Vacirca file Form 4?
Jeff L Vacirca has filed Form 4 at CAI (Caris Life Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.